BioCentury
ARTICLE | Company News

Spark, Pfizer deal

January 6, 2017 9:35 PM UTC

Spark received a $15 million milestone payment under a December 2014 deal granting Pfizer rights to develop and commercialize SPK-9001 (SPK-FIX). The milestone, the second under the deal, was triggere...